TAO Zufan,AKIBA S,ZHA Yongru,et al.Analysis of data (1987-1995) from investigation of cancer mortality in high background radiation area of Yangjiang, China[J].Chinese Journal of Radiological Medicine and Protection,1999,19(2):75-82
Analysis of data (1987-1995) from investigation of cancer mortality in high background radiation area of Yangjiang, China
Received:October 07, 1998  Revised:November 20, 1998
DOI:
KeyWords:High background radiation area  Cancer mortality  Relative risk  Excess relative risk coefficient
FundProject:
Author NameAffiliation
TAO Zufan Laboratory of Industrial Hygiene, Ministry of Health, Beijing 100088, China 
AKIBA S 日本鹿儿岛大学 
ZHA Yongru 广东省职业病防治院 
加藤宽夫 日本放射线影响研究所 
孙全富 Laboratory of Industrial Hygiene, Ministry of Health, Beijing 100088, China 
邹剑明 广东省职业病防治院 
李嘉 Laboratory of Industrial Hygiene, Ministry of Health, Beijing 100088, China 
刘玉升 Laboratory of Industrial Hygiene, Ministry of Health, Beijing 100088, China 
菅原努 日本体质研究会 
魏履新 Laboratory of Industrial Hygiene, Ministry of Health, Beijing 100088, China 
Hits: 3662
Download times: 2090
Abstract::
      Objective This investigation is a special project of High Background Radiation Research Group.The objective of the cancer mortality study in the high background radiation area (HBRA) of Yangjiang,China,which was started in 1972,was to estimate cancer risk associated with the low level radiation exposure of average annual effective dose of 6.4 mSv in HBRA.Since 1991,the study has been conducted collaboratively by Chinese and Japanese scientists with the purpose of accumulating further person years (Pyr) of observation for improving the statistical precision and seeing the reproducibility of the previous results. Methods The cancer mortality data of 1987-1995 covered in the current cooperative study were collected by a retrospective and/or prospective survey from a fixed cohort.The mortality investigation on the spot consisted of two steps,i.e.the follow-up of members in the cohort and the ascertainment of the death causes.Based on the hamlet specific average annual external dose,the members of the cohort in HBRA were classified into three groups:high,medial and low dose groups.Risk comparisons between each of the three dose groups with the control group from control area (CA) were conducted by means of relative risk (RR).The RR and the excess relative risk coefficient (ERR per sievert) and their 95% confidence interval (CI) were estimated using AMFIT program in Epicure. Results During the period 1987 1995,there were 5161 total deaths and 557 cancer deaths among 926238 Pyr at risk in the cohort of 106517 subjects.The RR (95% CI) adjusted for sex and age group for all cancers of whole HBRA was 0.96 (0.80- 1.15).As for the site specific cancer of whole HBRA,the RRs for leukemia,cancers of nasopharynx,esophagus and intestine were larger than one,while the RRs for cancers of stomach,liver,lungs,female breast,thyroid and lymphoma were less than one.However,all of them were not statistically different from one (P >0.05 for all).The homogeneity tests of RRs for all cancers and for site specific cancer among the three dose groups in HBRA revealed that the RRs among the dose groups were not different statistically ( P >0.05 for all).The results of RR estimation based on the combined data of 1979-1995,which included 125079 subjects,and total deaths of 10415 and cancer deaths of 1003 among 1698350 Pyr at risk,were generally consistent with those based on the data of 1987 1995 mentioned above.The RR (95%CI) for all cancers of whole HBRA was 0.99 (0.87 1.14) and the ERR (95%CI)/Sv of all cancers for both sexes and all ages was 0.10(-0.67,0.69) resulting from the combined data. Conclusione The results from data of different periods demonstrated that an increased cancer risk associated with the high levels of natural radiation in HBRA was not found;on the contrary,there was a trend that the mortality of all cancers in HBRA was generally lower than that in CA,but not significantly different statistically.
HTML  View Full Text  View/Add Comment  Download reader
Close

Copyright©    Editorial Office of Chinese Journal of Radiological Medicine and Protection    

Beijing ICP No. 05020547 -2

Address: 2 Xinkang Street, Dewai, Beijing 100088, China

Telephone:010-62389620; Email:cjrmp@cjrmp.sina.net

Technical Support:Beijing E-tiller CO.,LTD.

Visitors:12041042  On-line:0

v
Scan QR Code
&et=6FD48CA0A0DD4759E7055A8965167ECC048946ED0FFDC0591C47CDB1DD3DE474CD061184C31820256E7522231FE6C3E8B92B0E9B3F11489B5712D3B2595A3BC356DB8B84C1C4DB76CA1E5FC2BD774B3E47BF4D6C2CAF969119CA25A83D4E04C92E32D6408DE4BA006033CB8305733705C4354DAF8D79C97F51A2F194F1FB23EA&pcid=A9DB1C13C87CE289EA38239A9433C9DC&cid=D4D466D60FDC1A5A&jid=5E4353813E091AB841B02B880782B82C&yid=B914830F5B1D1078&aid=90F42D17E7258B6AEDB475195753EE01&vid=&iid=0B39A22176CE99FB&sid=80A07035DF96B0C4&eid=0D0D661F0B316AD5&fileno=19990203&flag=1&is_more=0"> var my_pcid="A9DB1C13C87CE289EA38239A9433C9DC"; var my_cid="D4D466D60FDC1A5A"; var my_jid="5E4353813E091AB841B02B880782B82C"; var my_yid="B914830F5B1D1078"; var my_aid="90F42D17E7258B6AEDB475195753EE01";